Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.86.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.86.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.86.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.86.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.33EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.33ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.33ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.13.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.13.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.13.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.13.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.13.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCMEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCMECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCMECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCMEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCMEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HN.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HN.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HN.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.13.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.13.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.13.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.13.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used